| Financial Year |
March 31 2023 |
| Monetary Funds |
1,315,105,552.29 |
| Held-for-trading Financial Assets |
6,943,546.44 |
| Notes Receivable |
31,729,480.35 |
| Accounts Receivable |
563,608,953.96 |
| Advances to Suppliers |
65,166,392.34 |
| Other Receivables |
19,653,695.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,176,876.55 |
| Inventories |
1,968,822,860.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,775,592.74 |
| Total Current Assets |
4,039,404,352.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
20,911,760.85 |
| Investment Properties |
116,325,230.26 |
| Fixed Assetes |
3,052,105,421.51 |
| Under-construction Projects |
845,583,009.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
461,020,314.57 |
| R&D expenses |
5,425,831.21 |
| Goodwill |
683,499,314.27 |
| Long-Term Deferred and Prepaid Expenses |
34,535,481.33 |
| Deferred Income Tax Assets |
114,337,737.29 |
| Other Non-Current Assets |
104,033,390.05 |
| Sub-Total of Non-Current Assets |
5,488,556,324.12 |
| Total Assets |
9,527,960,676.15 |
| Short-Term Loans |
97,230,312.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,674,166.90 |
| Accounts Payable |
727,412,742.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
205,514,497.32 |
| Taxes Payable |
136,165,266.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
230,019,648.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
316,497,467.58 |
| Other Current Liabilities |
817,730.83 |
| Sub-Total of Current Liabilities |
1,856,113,923.36 |
| Long-term Loans |
584,802,638.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,076,522.30 |
| Deferred Income Tax Liabilities |
9,742,980.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
695,829,833.66 |
| Total Liabilities |
2,551,943,757.02 |
| Paid-In Capital(Or Share Stock) |
930,130,215.00 |
| Capital Surplus |
2,515,082,399.52 |
| Surplus Reserve |
379,862,056.54 |
| LESS:Treasury Stock |
199,996,425.00 |
| Undistributed Profits |
2,803,930,278.37 |
| Minority Stockholder's Interest |
512,136,730.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,463,880,188.92 |
| Owner's Equity（Stockholder's Equity） |
6,976,016,919.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,527,960,676.15 |
